Selected Publications

2021

American Society of Transplantation and Cellular Therapy Series, 2: Management and Prevention of Aspergillosis in Hematopoietic Cell Transplantation Recipients. Dadwal SS, Hohl TM, Fisher CE, Boeckh M, Papanicolaou G, Carpenter PA, Fisher BT, Slavin MA, Kontoyiannis DP. Transplant Cell Ther. 2021 Mar;27(3):201-211. doi: 10.1016/j.jtct.2020.10.003.Transplant Cell Ther. 2021. PMID: 33781516

Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): A comparison with influenza associated aspergillosis (IAPA). Lamoth F, Lewis RE, Walsh TJ, Kontoyiannis DP.. J Infect Dis. 2021 Mar 26:jiab163. doi: 10.1093/infdis/jiab163. J Infect Dis. 2021. PMID: 33770176

EGF-mediated suppression of cell extrusion during mucosal damage attenuates opportunistic fungal invasion. Wurster S, Ruiz OE, Samms KM, Tatara AM, Albert ND, Kahan PH, Nguyen AT, Mikos AG, Kontoyiannis DP, Eisenhoffer GT.. Cell Rep. 2021 Mar 23;34(12):108896. doi: 10.1016/j.celrep.2021.108896.Cell Rep. 2021. PMID: 33761358

Molecular Techniques for Genus and Species Determination of Fungi From Fresh and Paraffin-Embedded Formalin-Fixed Tissue in the Revised EORTC/MSGERC Definitions of Invasive Fungal Infection. Lockhart SR, Bialek R, Kibbler CC, Cuenca-Estrella M, Jensen HE, Kontoyiannis DP.. Clin Infect Dis. 2021 Mar 12;72(Supplement_2):S109-S113. doi: 10.1093/cid/ciaa1836.Clin Infect Dis. 2021. PMID: 33709128

Disseminated cryptococcosis and anti-granulocyte-macrophage colony-stimulating factor autoantibodies: An underappreciated association. Viola GM, Malek AE, Rosen LB, DiNardo AR, Nishiguchi T, Okhuysen PC, Holland SM, Kontoyiannis DP.Viola GM, et al. Among authors: kontoyiannis dp. Mycoses. 2021 Jan 21. doi: 10.1111/myc.13247. Mycoses. 2021. PMID: 33476401

2020

Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections. Lamoth F, Lewis RE, Kontoyiannis DP.. J Fungi (Basel). 2020 Dec 30;7(1):17. doi: 10.3390/jof7010017.J Fungi (Basel). 2020. PMID: 33396870

Knowledge gaps in candidaemia/invasive candidiasis in haematological cancer patients. Colombo AL, Agnelli C, Kontoyiannis DP. J Antimicrob Chemother. 2021 Feb 11;76(3):543-546. doi: 10.1093/jac/dkaa446.J Antimicrob Chemother. 2021. PMID: 33150364

Live imaging and quantitative analysis of Aspergillus fumigatus growth and morphology during inter-microbial interaction with Pseudomonas aeruginosa. Wurster S, Sass G, Albert ND, Nazik H, Déziel E, Stevens DA, Kontoyiannis DP. Virulence. 2020 Dec;11(1):1329-1336. doi: 10.1080/21505594.2020.1827885.Virulence. 2020. PMID: 33017225

How I transplant a patient with a history of invasive fungal disease. Puerta-Alcalde P, Champlin R, Kontoyiannis DP. Blood. 2020 Aug 26:blood.2020005884. doi: 10.1182/blood.2020005884. Blood. 2020. PMID: 32845974

Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium. Johnson MD, Lewis RE, Dodds Ashley ES, Ostrosky-Zeichner L, Zaoutis T, Thompson GR, Andes DR, Walsh TJ, Pappas PG, Cornely OA, Perfect JR, Kontoyiannis DP. J Infect Dis. 2020 Aug 5;222(Suppl 3):S175-S198. doi: 10.1093/infdis/jiaa394.J Infect Dis. 2020. PMID: 32756879 Review.

Combination antifungal therapy for breakthrough invasive mould disease in patients with haematological malignancies: when management reasoning eclipses evidence-based medicine. Garcia-Vidal C, Lewis RE, Kontoyiannis DP.. J Antimicrob Chemother. 2020 Nov 1;75(11):3096-3098. doi: 10.1093/jac/dkaa281

Serum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR. Szvalb AD, Malek AE, Jiang Y, Bhatti MM, Wurster S, Kontoyiannis DP. J Infect. 2020 Sep;81(3):443-451. doi: 10.1016/j.jinf.2020.07.003. Epub 2020 Jul 7.J Infect. 2020. PMID: 32650108

Tornadic Shear Stress Induces a Transient, Calcineurin-Dependent Hypervirulent Phenotype in Mucorales Molds. Wurster S, Tatara AM, Albert ND, Ibrahim AS, Heitman J, Lee SC, Shetty AC, McCracken C, Graf KT, Mikos AG, Bruno VM, Kontoyiannis DP. mBio. 2020 Jun 30;11(3):e01414-20. doi: 10.1128/mBio.01414-20.mBio. 2020. PMID: 32605990

Protective Activity of Programmed Cell Death Protein 1 Blockade and Synergy With Caspofungin in a Murine Invasive Pulmonary Aspergillosis Model. Wurster S, Robinson P, Albert ND, Tarrand JJ, Goff M, Swamydas M, Lim JK, Lionakis MS, Kontoyiannis DP.. J Infect Dis. 2020 Aug 17;222(6):989-994. doi: 10.1093/infdis/jiaa264.J Infect Dis. 2020. PMID: 32432714

The gut mycobiome: The overlooked constituent of clinical outcomes and treatment complications in patients with cancer and other immunosuppressive conditions. Galloway-Peña JR, Kontoyiannis DP.Galloway-Peña JR, et al.. PLoS Pathog. 2020 Apr 2;16(4):e1008353. doi: 10.1371/journal.ppat.1008353. eCollection 2020 Apr.PLoS Pathog. 2020. PMID: 32240277

Isavuconazole as Primary Anti-Fungal Prophylaxis in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective, Phase II Study. Bose P, McCue D, Wurster S, Wiederhold NP, Konopleva M, Kadia TM, Borthakur G, Ravandi F, Masarova L, Takahashi K, Zeev E, Yilmaz M, Daver N, Pemmaraju N, Naqvi K, Rausch CR, Marx KR, Qiao W, Huang X, Bivins CA, Pierce SA, Kantarjian HM, Kontoyiannis DP.. Clin Infect Dis. 2020 Apr 1:ciaa358. doi: 10.1093/cid/ciaa358. Clin Infect Dis. 2020. PMID: 32236406

How Long Do We Need to Treat an Invasive Mold Disease in Hematology Patients? Factors Influencing Duration of Therapy and Future Questions. Fernández-Cruz A, Lewis RE, Kontoyiannis DP. Clin Infect Dis. 2020 Jul 27;71(3):685-692. doi: 10.1093/cid/ciz1195.Clin Infect Dis. 2020. PMID: 32170948

Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients. Lamoth F, Kontoyiannis DP.. Antimicrob Agents Chemother. 2019 Oct 22;63(11):e01244-19. doi: 10.1128/AAC.01244-19. Print 2019 Nov. Antimicrob Agents Chemother. 2019. PMID: 31481441

Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia. Galloway-Peña JR, Shi Y, Peterson CB, Sahasrabhojane P, Gopalakrishnan V, Brumlow CE, Daver NG, Alfayez M, Boddu PC, Khan MAW, Wargo JA, Do KA, Jenq RR, Kontoyiannis DP, Shelburne SA. Clin Infect Dis. 2020 Jun 24;71(1):63-71. doi: 10.1093/cid/ciz777.Clin Infect Dis. 2020. PMID: 31436833

2019

Live Monitoring and Analysis of Fungal Growth, Viability, and Mycelial Morphology Using the IncuCyte NeuroTrack Processing Module. Wurster S, Kumaresan PR, Albert ND, Hauser PJ, Lewis RE, Kontoyiannis DP. mBio. 2019 May 28;10(3):e00673-19. doi: 10.1128/mBio.00673-19.mBio. 2019. PMID: 31138745

Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris. Wurster S, Bandi A, Beyda ND, Albert ND, Raman NM, Raad II, Kontoyiannis DP. J Antimicrob Chemother. 2019 Jul 1;74(7):1904-1910. doi: 10.1093/jac/dkz100.J Antimicrob Chemother. 2019. PMID: 31225606

Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study. Galloway-Peña JR, Peterson CB, Malik F, Sahasrabhojane PV, Shah DP, Brumlow CE, Carlin LG, Chemaly RF, Im JS, Rondon G, Felix E, Veillon L, Lorenzi PL, Alousi AM, Jenq RR, Kontoyiannis DP, Shpall EJ, Shelburne SA, Okhuysen PC.Galloway-Peña JR, et al. Among authors: kontoyiannis dp. Open Forum Infect Dis. 2019 Apr 4;6(5):ofz173. doi: 10.1093/ofid/ofz173. eCollection 2019 May.Open Forum Infect Dis. 2019. PMID: 31065565

Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for In Vitro Eradication of Candida auris Biofilm. Vargas-Cruz N, Reitzel RA, Rosenblatt J, Chaftari AM, Wilson Dib R, Hachem R, Kontoyiannis DP, Raad II. Antimicrob Agents Chemother. 2019 Jun 24;63(7):e00299-19. doi: 10.1128/AAC.00299-19. Print 2019 Jul. Antimicrob Agents Chemother. 2019. PMID: 31036689

Culture-Documented Invasive Mold Infections at MD Anderson Cancer Center in Houston, Texas, Pre- and Post-Hurricane Harvey. Kontoyiannis DP, Shah EC, Wurster S, Aitken SL, Graviss L, Raad II, Chemaly RF.Kontoyiannis DP, et al. Open Forum Infect Dis. 2019 Apr 2;6(4):ofz138. doi: 10.1093/ofid/ofz138. eCollection 2019 Apr.Open Forum Infect Dis. 2019. PMID: 31024975

Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies. Stanzani M, Vianelli N, Cavo M, Kontoyiannis DP, Lewis RE.. J Infect. 2019 Jun;78(6):484-490. doi: 10.1016/j.jinf.2019.04.002. Epub 2019 Apr 8.J Infect. 2019. PMID: 30974130